Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 94, 178-182
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluationSeizure: European Journal of Epilepsy, 2015
- Lacosamide monotherapy for partial onset seizuresSeizure: European Journal of Epilepsy, 2015
- A randomized, double‐blind comparison of antiepileptic drug treatment in the elderly with new‐onset focal epilepsyEpilepsia, 2015
- Conversion to lacosamide monotherapy in the treatment of focal epilepsy: Results from a historical‐controlled, multicenter, double‐blind studyEpilepsia, 2014
- Common comorbidities in women and men with epilepsy and the relationship between number of comorbidities and health plan paid costs in 2010Epilepsy & Behavior, 2014
- Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromesEpilepsia, 2013
- Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsyEpilepsy Research, 2012
- The safety and efficacy of add-on levetiracetam in elderly patients with focal epilepsy: A one-year observational studySeizure: European Journal of Epilepsy, 2011
- Epilepsy in the elderly: facts and challengesActa Neurologica Scandinavica, 2010
- The epidemiology of epilepsy in Europe – a systematic reviewEuropean Journal of Neurology, 2005